Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
- PMID: 18264098
- PMCID: PMC3598012
- DOI: 10.1038/ng.89
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Abstract
We conducted a genome-wide SNP association study on prostate cancer on over 23,000 Icelanders, followed by a replication study including over 15,500 individuals from Europe and the United States. Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.
Conflict of interest statement
The authors declare competing financial interests: details accompany the full-text HTML version of the paper at
References
Publication types
MeSH terms
Grants and funding
- P50 CA058236/CA/NCI NIH HHS/United States
- CA86323/CA/NCI NIH HHS/United States
- U01 CA086323/CA/NCI NIH HHS/United States
- CA105055/CA/NCI NIH HHS/United States
- R01 CA105055/CA/NCI NIH HHS/United States
- CA95052/CA/NCI NIH HHS/United States
- CA106523/CA/NCI NIH HHS/United States
- R01 CA106523/CA/NCI NIH HHS/United States
- R01 CA095052/CA/NCI NIH HHS/United States
- UL1 RR025741/RR/NCRR NIH HHS/United States
- CA112517/CA/NCI NIH HHS/United States
- CA58236/CA/NCI NIH HHS/United States
- R01 CA112517/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases